Search Results 521-530 of 16051 for Residual
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...
Learn about symptoms that alert doctors to a breast cancer recurrence and strategies for treating cancer that comes back after initial treatment.
... residual colon/rectum/pouch as the primary disease site. Transforming Healthcare and Outcomes for Children with Inflammatory Bowel Disease. La Crosse, Wis ...
A Study to Evaluate the Surgical Removal of Residual Brain Tumors Prior to Recurrence. Rochester, Minn. The purpose of this study is to evaluate the safety ...
The use of acetylsalicylic acid and eflornithine may prevent colorectal cancer. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Rochester, ...
It's a procedure that could help up to 60,000 people in the U.S. whose voice boxes have been damaged by injury, cancer, or the residual effects of radiation ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
CLL monitoring minimal residual disease (MRD) detection. While not yet approved by the Food and Drug Administration, hematologists look to this flow ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.